Clinical Research and Clinical Trials Laboratory, Hamilton General Hospital, Hamilton, Ontario, Canada.
Clin Chem. 2011 Apr;57(4):577-85. doi: 10.1373/clinchem.2010.156380. Epub 2011 Feb 4.
Stability and transport challenges make hemoglobin (Hb) A(1c) measurement from EDTA whole blood (WB) inconvenient and costly for large-scale population studies. This study investigated Hb A(1c) measurement from WB blotted on filter paper (FP) in a Level I National Glycohemoglobin Standardization Program (NGSP)-accredited laboratory.
Three Bio-Rad Variant™ II HPLC instruments and WB and FP specimens were used. Precision, accuracy, linearity, and readable total area of the 6.5-min (β-thalassemia method) Variant II HbA(2)/HbA(1c) Dual Program were assessed. Hb A(1c) stability was measured using in-house FP QC samples. The INTERHEART (a study of the effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries) and CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events) studies provided chromatographs for morphometric analyses and interoperator variability experiments. Statistical analyses were performed to assess long-term sample stability, WB vs FP agreement, and significance of Hb A(1c) peak integration.
Intra- and interassay CVs were ≤2.00%. Total area counts between 0.8 and 5.5 × 10(6) μV/s produced accurate Hb A(1c) results. The regression equation for agreement between WB(x) and FP(y) was as follows: y = 0.933x + 0.4 (n = 85). FP QC samples stored at -70 °C and tested over approximately 3 years yielded CVs of 1.72%-2.73% and regression equations with slopes of -1.08 × 10(-4) to 7.81 × 10(-4). The CURE study, with better preanalytical preparation, achieved a 97% reportable rate, and the reportable rate of the INTERHEART study was 85%.
The FP collection method described provided accurate, robust, and reproducible measurement of Hb A(1c) using the Bio-Rad Variant II HPLC autoanalyzer when FP specimens were prepared according to standardized protocols, and analyses were performed in an NGSP-certified laboratory, supporting the use of FP collection cards in large multinational studies.
对于大规模的人群研究来说,由于稳定性和运输方面的挑战,从 EDTA 全血(WB)中测量血红蛋白(Hb)A(1c)既不方便也不经济。本研究调查了在一级国家糖化血红蛋白标准化计划(NGSP)认证实验室中,从点在滤纸上的 WB(FP)测量 Hb A(1c)。
使用了三台 Bio-Rad Variant II HPLC 仪器和 WB 和 FP 标本。评估了 6.5 分钟(β-地中海贫血法)Variant II HbA(2)/HbA(1c)双程序的精密度、准确性、线性和可读总面积。使用内部 FP QC 样本测量 Hb A(1c)的稳定性。INTERHEART(一项研究与心肌梗死相关的 52 个国家中潜在可改变的风险因素的影响)和 CURE(氯吡格雷不稳定型心绞痛预防复发)研究提供了用于形态计量分析和操作员间变异性实验的色谱图。进行了统计分析,以评估长期样本稳定性、WB 与 FP 的一致性以及 Hb A(1c)峰积分的意义。
批内和批间 CVs 均≤2.00%。在 0.8 至 5.5×10(6)μV/s 之间的总面积计数可产生准确的 Hb A(1c)结果。WB(x)与 FP(y)之间的一致性回归方程如下:y=0.933x+0.4(n=85)。在-70°C 下储存的 FP QC 样本,在大约 3 年内测试,CVs 为 1.72%-2.73%,回归方程的斜率为-1.08×10(-4)至 7.81×10(-4)。具有更好的预分析准备的 CURE 研究达到了 97%的可报告率,而 INTERHEART 研究的可报告率为 85%。
当按照标准化方案制备 FP 标本并在 NGSP 认证实验室中进行分析时,描述的 FP 采集方法使用 Bio-Rad Variant II HPLC 自动分析仪提供了准确、稳健和可重复的 Hb A(1c)测量,支持在大型跨国研究中使用 FP 采集卡。